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in Ontario (ONT) and to develop recommendations to ensure all 
patients to have equitable access to MR-guided brachytherapy 
(MRgBT) for cervical cancer. 
Methods: A qualitative phone interview was designed by the GYN 
CoP working group to survey the current state of ccBT in the 
province. Questions were developed to inquire about the current 
use of image-guided ccBT and the associated referral processes, 
the usage of MR imaging in ccBT and the current use of image-
guided interstitial GYN BT. All ONT cancer centres offering 
radiation treatments to GYN cancers were included. Two group 
members conducted and audio recorded the telephone 
interviews from May to November 2015 and analyzed all 
recordings and summarized the data. 
Results: Thirteen (n = 13) ONT cancer centres were interviewed. 
Of these, three centres do not offer ccBT, five centres offer CT-
guided ccBT, four centres offer a combination of CT-MR-guided 
ccBT and one centre offers strictly MR-guided ccBT. The three 
centres that do not offer ccBT have established referral 
processes with three tertiary cancer centres in ONT respectively. 
However, there is no standardized referral process, referral 
timing, or method of communication. Other practices vary 
throughout the centres. Three of 13 centres suggested 
developing a file portal to standardize and facilitate the sharing 
of external beam and BT plans, distributions and images. All CT-
guided ccBT centres except one have plans to develop MRgBT. 
The tertiary centres mentioned above are also the only centres 
that offer interstitial GYN BT. They are located in the 
southwestern part of the province. Of these, one centre offers 
CT-guided and two centres offer MR-guided interstitial GYN BT. 
There is currently no standardized guideline to identify patient 
candidates for interstitial GYN BT. 
Conclusions: This study demonstrated that models of shared 
care exist and are functioning in ONT. While referral processes 
are functioning well, some areas represent opportunities for 
improvement. Future work is needed by the GYN CoP to improve 
referral processes and to develop consensus on indications for 
interstitial brachytherapy. This will ensure all patients in ONT 
have access to this high quality brachytherapy.  
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Purpose: To determine the optimal patient positioning and most 
reliable measurements for placement of skin marks during the 
mark-up procedure prior to PBSI brachytherapy for breast 
cancer. 
Methods and Materials: A retrospective chart review was 
conducted among patients who had imaging assessments to 
determine eligibility for PBSI following breast conserving surgery 
for Stage 0-1 breast cancer. Eligible patients had received CT 
imaging to determine the size and location of the seroma. 
Patients had treatment plans created, with a CT reference 
marker placed on the medial aspect of the nipple and tattoos 
consistent with standard institutional practice for external beam 
radiation treatments (EBRT). For patients receiving PBSI, skin 
markings were placed on the patient’s breast to map the 
implant, on the morning of the procedure. The interval from 
planning CT to implant date was two to four weeks. For this 
study, mark-up and delivery data were documented and 
deviations between planning CT and implant data for PBSI, were 
reviewed to determine the most reliable measurements for 
patient positioning and mark-up. 
Results: Among 40 patients initially assessed for PBSI, 27 
proceeded to implant and 13 ineligible patients (seroma too 
large or close to skin) had EBRT. The EBRT set-up tattoos used in 
PBSI were observed to have significant deviations from the 
planning CT, due to the variation in arm placement between the 
two treatment modalities. Measurements to determine the 
fiducial entry point referencing the nipple marker were 
determined to have a mean deviation of < 1 mm while those from 
the table top to the tattoo was 6mm and from the table top to 
the fiducial was 8 mm. 
Conclusions: Two-thirds of patients assessed were eligible and 
received PBSI. Temporary markings should be used at the time 
of assessment CT with permanent tattoos applied only after of 
the treatment modality is finalized. Measurements from the 
table are less reliable than those referencing the nipple marker. 
Set-up variations on the table top, possibly due to loose tissue 
and patient rotation, make measurements referencing patient’s 
markings the most reliable. 
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Purpose: To propose an effective training program for radiation 
therapy teams starting to implement PBSI brachytherapy for 
early stage breast cancer. 
Methods and Materials: A PBSI program requires a 
multidisciplinary team including physicians, physicists, 
dosimetrists, radiation therapists, operating room nurses, 
anesthetists, machinists and administrative personnel. A PBSI 
program was launched in 2013. Multiple CT and ultrasound 
compatible gel phantoms that mimicked breast tissue with 
embedded seromas, were designed and constructed. Physicians 
practiced ultrasound guided needle placement into numerous 
phantoms, with seromas in various locations, to simulate actual 
patient implants. Post-implant CT scans of phantoms were used 
to assess implant accuracy. Observations recorded prospectively 
during the practice implants on phantoms and mock PBSI 
deliveries were used to guide process development, improve 
quality and refine training, education, and experience. 
Results: Based on our development research, results, and 
experience, we suggest that a centre starting a PBSI program 
should have an onsite training course that includes the following 
modules: 
1) PBSI theory: including background, patient eligibility, patient 
assessments and suitability, process from assessment to 
treatment and patient care; 
2) Treatment planning session: including dosimetric goals and 
objectives, hands on clinical case examples with comparison to 
benchmark plans and guided physician evaluation; 
3) Participant observation of a PBSI operating room procedure; 
4) Active involvement of the participants in practice sessions 
with phantoms and realistic operating room scenarios; 
5) Wrap up session: opportunity to share experiences and 
problem solve. Group discussion on how to translate their 
learning to their own practice. Feedback from participants on 
this training program and areas for improvement; and 
6) Follow up: remote pre-plan consults and/or reviews as well as 
post-plan analyses for several cases. 
Conclusions: Effective training with hands on experience 
followed by support after centre implementation will improve 
the learning curve, increase confidence, and assist radiation 
therapy teams to set up a breast brachytherapy program in their 
department. 
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Purpose: The risk of tumour progression and recurrence is an 
important consideration when treating prostate cancer. Risk 
assessment includes clinical staging through physical 
